scholarly article | Q13442814 |
P50 | author | J Wouter Jukema | Q64858750 |
Saskia C A de Jager | Q73812155 | ||
Douwe Ekke Atsma | Q89053244 | ||
Martin Jan Schalij | Q89053249 | ||
Erik A L Biessen | Q114371052 | ||
Bas L van der Hoeven | Q114403325 | ||
P2093 | author name string | Hein Putter | |
Theo J C van Berkel | |||
Berent J Prakken | |||
Wilco de Jager | |||
Su-San Liem | |||
Adriaan O Kraaijeveld | |||
Robert W Grauss | |||
P2860 | cites work | Pravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase | Q28362055 |
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. | Q33183129 | ||
Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. | Q33212030 | ||
Stem cell-related cardiac gene expression early after murine myocardial infarction | Q33268468 | ||
Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells | Q34579137 | ||
Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. | Q35047585 | ||
The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats | Q35844081 | ||
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts | Q36509613 | ||
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms | Q40168375 | ||
Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions | Q40420958 | ||
Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium | Q40423150 | ||
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk | Q40753513 | ||
Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet | Q43654962 | ||
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. | Q44063984 | ||
RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients | Q44506407 | ||
Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes | Q44579499 | ||
Serum MCP-1 and VEGF levels are not affected by inhibition of the renin-angiotensin system in patients with acute myocardial infarction | Q44628723 | ||
Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells | Q45257699 | ||
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy | Q46191844 | ||
Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. | Q46434904 | ||
Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection | Q47433273 | ||
Molecular dynamics of the compensatory response to myocardial infarct. | Q52061500 | ||
Elevated plasma interleukin-6 levels in patients with acute myocardial infarction | Q72630338 | ||
Relationship between CRP and clinical course of unstable angina depends on assay method | Q73078663 | ||
Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction | Q73088379 | ||
Platelet-derived CD40L: the switch-hitting player of cardiovascular disease | Q74627856 | ||
Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population | Q77094964 | ||
Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function | Q77777637 | ||
Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling | Q77815083 | ||
Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease | Q79374759 | ||
MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction | Q79438237 | ||
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 | Q79851935 | ||
Simvastatin exerts its anti-inflammatory effect in hypercholesterolaemic patients by decreasing the serum levels of monocyte chemoattractant protein-1 | Q80073011 | ||
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome | Q80288412 | ||
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis | Q80431554 | ||
The role of the chemokines in myocardial ischemia and reperfusion | Q80472753 | ||
Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies | Q81751909 | ||
Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction | Q82458639 | ||
Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction | Q82917837 | ||
P433 | issue | 3 | |
P921 | main subject | acute coronary syndrome | Q266018 |
P1104 | number of pages | 7 | |
P304 | page(s) | 446-452 | |
P577 | publication date | 2008-06-21 | |
P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
P1476 | title | CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events | |
P478 | volume | 45 |
Q92153753 | A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia |
Q38826694 | CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events |
Q39035199 | Cardiometabolic biomarkers are predictors of readmission and death in patients hospitalized for acute dyspnea |
Q34672038 | Chemokine receptor CCR5: from AIDS to atherosclerosis |
Q34430115 | Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes |
Q37486616 | Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture |
Q37547865 | Conditional deletion of cardiomyocyte peroxisome proliferator-activated receptor γ enhances myocardial ischemia-reperfusion injury in mice |
Q39895236 | From multimarker approach to multiplex assays in acute coronary syndromes: what are we searching for? |
Q35633277 | Is PCOS an inflammatory process? |
Q39867198 | Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species |
Q30440919 | Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging |
Q34312170 | PEG-albumin plasma expansion increases expression of MCP-1 evidencing increased circulatory wall shear stress: an experimental study |
Q33576883 | PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease |
Q38810989 | Prognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade. |
Q37660659 | The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue |
Search more.